Fig. 3
From: The preclinical and clinical progress of cell sheet engineering in regenerative medicine
Major contributors in the field. A Japan has made the greatest progress in the field of CSE and iPSCs research, followed by China, the Republic of Korea, France, Sweden, and Thailand. Also, the number of registered clinical trials in each country was noted on the chart. B, C The bar graph indicates that 80% of trials have been registered in Japan. China and the Republic of Korea ranked second